Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.

Prolactin (PRL)-dependent signaling occurs as the result of ligand-induced homodimerization of the PRL receptor (PRLr). To date, short, intermediate, and long human PRLr isoforms have been characterized. To investigate the expression of other possible human PRLr isoforms, RT-PCR was performed on mRNA isolated from the breast carcinoma cell line T47D. A 1.5-kb PCR fragment was isolated, subcloned, and sequenced. The PCR product exhibited a nucleotide sequence 100% homologous to the human long isoform except bp 71-373 were deleted, which code for the S1 motif of the extracellular domain. Therefore, this isoform was designated the deltaS1 PRLr. Northern analysis revealed variable deltaS1 PRLr mRNA expression in a variety of tissues. Transfection of Chinese hamster ovary cells with deltaS1 cDNA showed the isoform is expressed at the protein level on the cell surface with a molecular mass of approximately 70 kDa. Kinetic studies indicated the deltaS1 isoform bound ligand at a lower affinity than wild-type receptor. The deltaS1 PRLr was also shown to activate the proximal signaling molecule Jak2 upon addition of ligand to transfected cells, and, unlike the long PRLr, high concentrations of ligand did not function as a self-antagonist to signaling during intervals of PRL serum elevation, i.e. stress and pregnancy. Given its apparent widespread expression, this PRLr isoform may contribute to PRL action. Furthermore, the functionality of this receptor raises interesting questions regarding the minimal extracellular domain necessary for ligand-induced receptor signaling.

[1]  M. Postel-Vinay Growth hormone- and prolactin-binding proteins: soluble forms of receptors. , 1996, Hormone research.

[2]  O. Riddle,et al.  THE PREPARATION, IDENTIFICATION AND ASSAY OF PROLACTIN—A HORMONE OF THE ANTERIOR PITUITARY , 1933 .

[3]  B. Groner,et al.  Hormonal regulation of transcription factor activity in mammary epithelial cells , 1994, Molecular and Cellular Endocrinology.

[4]  D. Linzer,et al.  Expression of multiple forms of the prolactin receptor in mouse liver. , 1989, Molecular endocrinology.

[5]  P. Kelly,et al.  Mutational analysis of the ligand-binding domain of the prolactin receptor. , 1991, The Journal of biological chemistry.

[6]  N. Horseman,et al.  Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene , 1997, The EMBO journal.

[7]  S. Loefas,et al.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. , 1991, Analytical biochemistry.

[8]  J. Wells,et al.  Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. , 1999, Biochemistry.

[9]  L. Yu-Lee,et al.  Prolactin gene expression in human thymocytes , 1992, Molecular and Cellular Endocrinology.

[10]  H. Rui,et al.  JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. , 1994, Endocrinology.

[11]  J. Martial,et al.  Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay* , 1996, The Journal of Biological Chemistry.

[12]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[13]  P. Donatsch,et al.  Localization of prolactin in rat kidney tissue using a double-antibody technique. , 1975, The Journal of endocrinology.

[14]  R. Lloyd,et al.  Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[15]  P. Kelly,et al.  The Prolactin/Growth Hormone Receptor Family: Structure/Function Relationships , 2004, Journal of Mammary Gland Biology and Neoplasia.

[16]  M. Ultsch,et al.  Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors , 1994, Protein science : a publication of the Protein Society.

[17]  T. Vanha-Perttula,et al.  Distribution of 125I-prolactin in mice and rats. Studies with whole-body and microautoradiography. , 1974, Hormone research.

[18]  J A Wells,et al.  Binding in the growth hormone receptor complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Kelly,et al.  Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. , 1989, Molecular endocrinology.

[20]  J. Djiane,et al.  Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. , 1996, Molecular endocrinology.

[21]  P. Kelly,et al.  The prolactin/growth hormone receptor family. , 1991, Endocrine reviews.

[22]  L. Schuler,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Prolactin Receptor Heterogeneity in Bovine Fetal and Maternal Tissues* , 2022 .

[23]  X. Chen,et al.  Cloning, expression, and mutational analysis of the pigeon prolactin receptor. , 1994, Endocrinology.

[24]  J. Martial,et al.  Biological Properties of Human Prolactin Analogs Depend Not Only on Global Hormone Affinity, but Also on the Relative Affinities of Both Receptor Binding Sites* , 1999, The Journal of Biological Chemistry.

[25]  A. Kossiakoff,et al.  Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor , 2000, Nature Structural Biology.

[26]  J. Grosclaude,et al.  Functional Heterodimerization of Prolactin and Growth Hormone Receptors by Ovine Placental Lactogen* , 2000, The Journal of Biological Chemistry.

[27]  P. Kelly,et al.  The human prolactin receptor in the fetal membranes, decidua, and placenta. , 1996, Journal of Clinical Endocrinology and Metabolism.

[28]  S. Liebhaber,et al.  Molecular biology of the growth hormone-prolactin gene system. , 1995, Vitamins and hormones.

[29]  J. Martial,et al.  Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. , 1996, Endocrine reviews.

[30]  J. Grosclaude,et al.  Real-time Kinetic Measurements of the Interactions between Lactogenic Hormones and Prolactin-Receptor Extracellular Domains from Several Species Support the Model of Hormone-induced Transient Receptor Dimerization* , 1996, The Journal of Biological Chemistry.

[31]  Alan Wells,et al.  Engineering epidermal growth factor for enhanced mitogenic potency , 1996, Nature Biotechnology.

[32]  A. Kantor,et al.  Large-scale preparation and characterization of recombinant ovine placental lactogen. , 1997, The Journal of endocrinology.

[33]  J. Meng,et al.  Isolation and Characterization of Two Novel Forms of the Human Prolactin Receptor Generated by Alternative Splicing of a Newly Identified Exon 11* , 2001, The Journal of Biological Chemistry.

[34]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[35]  N. Ben-Jonathan,et al.  Prolactin is a local growth factor in rat mammary tumors. , 1995, Endocrinology.

[36]  N. Staten,et al.  Extracellular domain of prolactin receptor from bovine mammary gland: expression in Escherichia coli, purification and characterization of its interaction with lactogenic hormones. , 1995, The Journal of endocrinology.

[37]  P. Kelly,et al.  Expression of prolactin and its receptor in human lymphoid cells. , 1992, Molecular endocrinology.

[38]  M. Ultsch,et al.  The X-ray structure of a growth hormone–prolactin receptor complex , 1994, Nature.

[39]  J. Djiane,et al.  Preparation of the extracellular domain of the rabbit prolactin receptor expressed in Escherichia coli and its interaction with lactogenic hormones. , 1994, The Journal of biological chemistry.

[40]  P. Kelly,et al.  Structural symmetry of the extracellular domain of the Cytokine/Growth hormone/Prolactin receptor family and Interferon receptors revealed by Hydrophobic Cluster Analysis , 1991, FEBS letters.

[41]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  John Calvin Reed,et al.  Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. , 1994, The Journal of biological chemistry.

[43]  P. Kelly,et al.  Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. , 1995, The American journal of physiology.

[44]  I. Forsyth Variation among species in the endocrine control of mammary growth and function: the roles of prolactin, growth hormone, and placental lactogen. , 1986, Journal of dairy science.

[45]  M. Tanaka,et al.  Double antenna structure of chicken prolactin receptor deduced from the cDNA sequence. , 1992, Biochemical and biophysical research communications.

[46]  M. Freemark,et al.  Pregnancy lactogens in the rat conceptus and fetus: circulating levels, distribution of binding, and expression of receptor messenger ribonucleic acid. , 1993, Endocrinology.

[47]  P. Kelly,et al.  Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. , 1994, The Journal of biological chemistry.

[48]  P. Kelly,et al.  The growth hormone/prolactin receptor family. , 1993, Recent progress in hormone research.

[49]  N. Reich,et al.  Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Kane Redefining cell death. , 1995, The American journal of pathology.

[51]  A. Katz,et al.  Prolactin metabolism in the rat: role of the kidney in degradation of the hormone. , 1981, The American journal of physiology.

[52]  S. Aiso,et al.  The prolactin gene is expressed in the mouse kidney. , 1999, Kidney international.

[53]  G. Gibori,et al.  Alpha 2-macroglobulin expression in the mesometrial decidua and its regulation by decidual luteotropin and prolactin. , 1992, Endocrinology.

[54]  P. Kelly,et al.  Preparation and characterization of recombinant prolactin receptor extracellular domain from rat , 1995, Molecular and Cellular Endocrinology.

[55]  C. Clevenger,et al.  Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor* , 1999, The Journal of Biological Chemistry.

[56]  C. Powell,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .

[57]  J. Tomaszewski,et al.  Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. , 1995, The American journal of pathology.

[58]  J. Djiane,et al.  Cloning, preparation and characterization of biologically active recombinant caprine placental lactogen. , 1998, The Journal of endocrinology.

[59]  J. Bazan,et al.  Haemopoietic receptors and helical cytokines. , 1990, Immunology today.

[60]  J. Proudman,et al.  Radioligand receptor assay for prolactin using chicken and turkey kidney membranes. , 1991, Comparative biochemistry and physiology. B, Comparative biochemistry.

[61]  P. Kelly,et al.  A limited cytoplasmic region of the prolactin receptor critical for signal transduction , 1994, Molecular and Cellular Endocrinology.

[62]  B. Groner,et al.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1994, The EMBO journal.

[63]  J. Wells,et al.  Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. , 1991, The Journal of biological chemistry.

[64]  C. Clevenger,et al.  Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Medaglia,et al.  The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. , 1994, Molecular endocrinology.

[66]  S. Anderson,et al.  Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules* , 1999, The Journal of Biological Chemistry.